199 related articles for article (PubMed ID: 24687923)
1. Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo.
Ottewell PD; Wang N; Brown HK; Reeves KJ; Fowles CA; Croucher PI; Eaton CL; Holen I
Clin Cancer Res; 2014 Jun; 20(11):2922-32. PubMed ID: 24687923
[TBL] [Abstract][Full Text] [Related]
2. Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo.
Wright LE; Harhash AA; Kozlow WM; Waning DL; Regan JN; She Y; John SK; Murthy S; Niewolna M; Marks AR; Mohammad KS; Guise TA
Oncotarget; 2017 Jan; 8(5):8406-8419. PubMed ID: 28039445
[TBL] [Abstract][Full Text] [Related]
3. Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.
Ubellacker JM; Haider MT; DeCristo MJ; Allocca G; Brown NJ; Silver DP; Holen I; McAllister SS
Breast Cancer Res; 2017 Mar; 19(1):23. PubMed ID: 28264701
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol for preventing medication-related osteonecrosis of the jaws in rats.
Vitale M; Corrêa MG; Ervolino E; Cirano FR; Ribeiro FV; Monteiro MF; Casati MZ; Pimentel SP
Oral Dis; 2024 Apr; 30(3):1462-1474. PubMed ID: 36807967
[TBL] [Abstract][Full Text] [Related]
5. Ozone Improved Bone Dynamic of Female Rats Using Zoledronate.
Lima Neto TJ; Delanora LA; Sá Simon ME; Carmo Ribeiro KH; Matsumoto MA; Quírino Louzada MJ; Shibli JA; Ervolino E; Faverani LP
Tissue Eng Part C Methods; 2024 Jan; 30(1):1-14. PubMed ID: 37933908
[TBL] [Abstract][Full Text] [Related]
6. Cone-Beam Computed Tomography to evaluate changes in trabecular lower jawbone microstructure caused by bone loss and antiresorptive treatment.
Avendano ME; Bonanno MS; Zeni Coronel EM; Marotte C; Zeni SN; Davison MR
Acta Odontol Latinoam; 2023 Dec; 36(3):131-139. PubMed ID: 38345274
[TBL] [Abstract][Full Text] [Related]
7. Restoring implant fixation strength in osteoporotic bone with a hydrogel locally delivering zoledronic acid and bone morphogenetic protein 2. A longitudinal in vivo microCT study in rats.
Siverino C; Tirkkonen-Rajasalo L; Freitag L; Günther C; Thompson K; Styger U; Zeiter S; Eglin D; Stadelmann VA
Bone; 2024 Mar; 180():117011. PubMed ID: 38176642
[TBL] [Abstract][Full Text] [Related]
8. The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis.
Hadji P; Coleman R; Gnant M; Green J
Ann Oncol; 2012 Nov; 23(11):2782-2790. PubMed ID: 22730099
[TBL] [Abstract][Full Text] [Related]
9. Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients.
Solomayer EF; Gebauer G; Hirnle P; Janni W; Lück HJ; Becker S; Huober J; Krämer B; Wackwitz B; Wallwiener D; Fehm T
Ann Oncol; 2012 Sep; 23(9):2271-2277. PubMed ID: 22383680
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay.
Fehm T; Zwirner M; Wallwiener D; Seeger H; Neubauer H
BMC Cancer; 2012 Jul; 12():308. PubMed ID: 22824103
[TBL] [Abstract][Full Text] [Related]
11. A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD.
Moe SM; Chen NX; Newman CL; Gattone VH; Organ JM; Chen X; Allen MR
J Bone Miner Res; 2014 Apr; 29(4):902-10. PubMed ID: 24038306
[TBL] [Abstract][Full Text] [Related]
12. Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice.
Yan W; Wang TY; Fan QM; Du L; Xu JK; Zhai ZJ; Li HW; Tang TT
Acta Pharmacol Sin; 2014 Jan; 35(1):124-34. PubMed ID: 24384612
[TBL] [Abstract][Full Text] [Related]
13. Zoledronic Acid Modulates Cytokine Expression and Mitigates Bone Loss during the Development of Induced Apical Periodontitis in a Mice Model.
Maia CA; Chaves HGDS; Benetti F; de Menezes GB; Antunes MM; Pinto KP; Silva EJNL; Sobrinho APR; Tavares WLF
J Endod; 2023 Nov; 49(11):1522-1528. PubMed ID: 37633518
[TBL] [Abstract][Full Text] [Related]
14. Effect of Acridine Orange and Zoledronic Acid on Bone Metastasis in Renal Cell Carcinoma.
Oya K; Tsuchie H; Nagasawa H; Hongo M; Kasukawa Y; Kudo D; Shoji R; Kasama F; Kawaragi T; Watanabe M; Tominaga K; Miyakoshi N
Anticancer Res; 2024 Jun; 44(6):2487-2495. PubMed ID: 38821618
[TBL] [Abstract][Full Text] [Related]
15. Identifying therapeutic biomarkers of zoledronic acid by metabolomics.
Li X; Wang ZY; Ren N; Wei ZY; Hu WW; Gu JM; Zhang ZL; Yu XT; Wang C
Front Pharmacol; 2023; 14():1084453. PubMed ID: 37180703
[TBL] [Abstract][Full Text] [Related]
16. Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo.
Haider MT; Hunter KD; Robinson SP; Graham TJ; Corey E; Dear TN; Hughes R; Brown NJ; Holen I
Bone; 2015 Dec; 81():581-592. PubMed ID: 26279137
[TBL] [Abstract][Full Text] [Related]
17. Tissue-Engineered Model of Human Osteolytic Bone Tumor.
Villasante A; Marturano-Kruik A; Robinson ST; Liu Z; Guo XE; Vunjak-Novakovic G
Tissue Eng Part C Methods; 2017 Feb; 23(2):98-107. PubMed ID: 28068876
[TBL] [Abstract][Full Text] [Related]
18. Polymeric Nanoformulation of Zoledronic Acid Rescues Osteoblasts from the Harmful Effect of its Native Form: An In Vitro Investigation of Cytotoxic Potential on Osteoblasts and Osteosarcoma Cells.
Dash P; Samal S; Prasad Panda G; Piras AM; Dash M
Macromol Biosci; 2023 Nov; 23(11):e2300211. PubMed ID: 37384621
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions.
George CN; Canuas-Landero V; Theodoulou E; Muthana M; Wilson C; Ottewell P
J Bone Oncol; 2020 Dec; 25():100317. PubMed ID: 32995253
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer-secreted factors perturb murine bone growth in regions prone to metastasis.
Chiou AE; Liu C; Moreno-Jiménez I; Tang T; Wagermaier W; Dean MN; Fischbach C; Fratzl P
Sci Adv; 2021 Mar; 7(12):. PubMed ID: 33731354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
